ARHGDIA Antikörper (AA 1-204)

Produktnummer ABIN969501

Produktdetails anti-ARHGDIA Antikörper

Target: ARHGDIA (rho GDP Dissociation Inhibitor (GDI) alpha (ARHGDIA))

Bindungsspezifität: AA 1-204

Reaktivität: Human

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser ARHGDIA Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), ELISA, Flow Cytometry (FACS), Immunocytochemistry (ICC)

Verwendungszweck: ARHGDIA Antibody

Aufreinigung: Purified antibody

Immunogen: Purified recombinant fragment of human ARHGDIA (AA: FULL(1-204)) expressed in E. Coli.

Klon: 2G3

Isotyp: IgG1

Anwendungsinformationen

Applikationshinweise:

ELISA: 1/10000

FCM: 1/200 - 1/400

ICC: 1/200 - 1/1000

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: Purified antibody in PBS with 0.05 % sodium azide.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.

Referenzen für anti-ARHGDIA Antikörper (ABIN969501)

Bartos, Ramakrishnan, Braga-Lagache, Hänzi, Durussel, Prakash Sridharan, Zhu, Sheehan, Hynes, Bonny, Moor: "Renal FGF23 signaling depends on redox protein Memo1 and promotes orthovanadate-sensitive protein phosphotyrosyl phosphatase activity." in: Journal of cell communication and signaling, (2022) (PubMed).

Boulter, Garcia-Mata, Guilluy, Dubash, Rossi, Brennwald, Burridge: "Regulation of Rho GTPase crosstalk, degradation and activity by RhoGDI1." in: Nature cell biology, Vol. 12, Issue 5, pp. 477-83, (2010) (PubMed).

Ronneburg, Span, Kantelhardt, Dittmer, Schunke, Holzhausen, Sweep, Dittmer: "Rho GDP dissociation inhibitor alpha expression correlates with the outcome of CMF treatment in invasive ductal breast cancer." in: International journal of oncology, Vol. 36, Issue 2, pp. 379-86, (2009) (PubMed).

Details zu ARHGDIA

Target: ARHGDIA (rho GDP Dissociation Inhibitor (GDI) alpha (ARHGDIA))

Andere Bezeichnung: ARHGDIA (ARHGDIA Produkte)

Synonyme: GDIA1 antikoerper, NPHS8 antikoerper, RHOGDI antikoerper, RHOGDI-1 antikoerper, Bles01 antikoerper, zgc:55554 antikoerper, zgc:77681 antikoerper, wu:fa96g11 antikoerper, ARHGDIA antikoerper, NV15502 antikoerper, 5330430M07Rik antikoerper, Gdi-1 antikoerper, Rho-GDI antikoerper, RhoDGI antikoerper, RhoGDI-1 antikoerper, arhgdia antikoerper, MGC84535 antikoerper, gdia1 antikoerper, rhogdi antikoerper, rhogdi-1 antikoerper, rhogdi1 antikoerper, Rho GDP dissociation inhibitor alpha antikoerper, Rho GDP dissociation inhibitor (GDI) alpha antikoerper, rho GDP-dissociation inhibitor 2 antikoerper, Rho GDP dissociation inhibitor (GDI) alpha L homeolog antikoerper, ARHGDIA antikoerper, Arhgdia antikoerper, arhgdia antikoerper, LOC100120432 antikoerper, arhgdia.L antikoerper

Hintergrund:

Description: Aplysia Ras-related homologs (ARHs), also called Rho genes, belong to the RAS gene superfamily encoding small guanine nucleotide exchange (GTP/GDP) factors. The ARH proteins may be kept in the inactive, GDP-bound state by interaction with GDP dissociation inhibitors, such as ARHGDIA

Aliases: GDIA1,RHOGDI,RHOGDI-1

Molekulargewicht: 26kDa

Gen-ID: 396

HGNC: 396

UniProt: P52565

Pathways: Neurotrophin Signalübertragung